简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

印度太阳制药完成与塔罗的合并

2024-06-24 20:02

  • Sun Pharmaceutical said on Monday that the India-based specialty generics company has completed its merger with the Israel-based Taro Pharmaceutical Industries (NYSE:TARO).
  • Sun Pharma acquired all the outstanding ordinary shares of Taro that it did not previously own for $43 per share.
  • Sun Pharma has been the majority shareholder of Taro since 2010, and the present deal makes Taro a private company.
  • Source: Press Release

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。